Thompson Tamar
SEC insider (Form 3/4/5 filer). CIK 0001839248. Director at CATALYST PHARMACEUTICALS, INC. (CPRX) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in CORAL GABLES, FL.
Companies Thompson Tamar has filed insider reports for
- CATALYST PHARMACEUTICALS, INC. (CPRX): Director
- Avidity Biosciences, Inc. (RNAM): Director
Thompson Tamar
CIK: 0001839248
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 15, 2026CPRX
CATALYST PHARMACEUTICALS, INC.
DispositionDirect3.8K shares at avg. $31.50$119K - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
DispositionDirect6.7K shares- - Dec 8, 2025CPRX
CATALYST PHARMACEUTICALS, INC.
ExerciseDirect1.4K shares- - Nov 21, 2025CPRX
CATALYST PHARMACEUTICALS, INC.
ExerciseDirect947 shares- - Nov 20, 2025CPRX
CATALYST PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
5.5K shares- - Nov 20, 2025CPRX
CATALYST PHARMACEUTICALS, INC.
AwardDirectOptions to purchase common stock
18.1K shares- - Jun 10, 2025RNA
Avidity Biosciences, Inc.
AwardDirect6.7K shares- - Dec 9, 2024CPRX
CATALYST PHARMACEUTICALS, INC.
ExerciseDirect1.4K shares- - Nov 21, 2024CPRX
CATALYST PHARMACEUTICALS, INC.
AwardDirectOptions to purchase common stock
23.2K shares- - Nov 21, 2024CPRX
CATALYST PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
2.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  CPRX CATALYST PHARMACEUTICALS, INC. | Disposition | 3,773 | $31.50 | $118,850 | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition | 6,692 | - | $0 | Direct |
| Dec 8, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | Exercise | 1,413 | - | - | Direct |
| Nov 21, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | Exercise | 947 | - | - | Direct |
| Nov 20, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | Award Restricted Stock Units | 5,468 | - | - | Direct |
| Nov 20, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | Award Options to purchase common stock | 18,115 | - | - | Direct |
| Jun 10, 2025 |  RNA Avidity Biosciences, Inc. | Award | 6,692 | - | - | Direct |
| Dec 9, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Exercise | 1,413 | - | $0 | Direct |
| Nov 21, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Award Options to purchase common stock | 23,248 | - | - | Direct |
| Nov 21, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Award Restricted Stock Units | 2,841 | - | - | Direct |
1-10 of 12 transactions